Flavio Curnis

12PUBLICATIONS
38CO-AUTHORS
Molecular targetsMedical devicesCancer diagnosisProteins and peptidesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 07, 2025
Blockade of αvβ6 and αvβ8 integrins with a chromogranin A-derived peptide inhibits TGFβ activation in tumors and suppresses tumor growth.

Anna Maria Gasparri, Arianna Pocaterra, Barbara Colombo

|Sep 05, 2024
Gold nanorod-assisted theranostic solution for nonvisible residual disease in bladder cancer.

Paolo Armanetti, Irene Locatelli, Chiara Venegoni

|Jan 30, 2024
A novel aminopeptidase N/CD13 inhibitor selectively targets an endothelial form of CD13 after coupling to proteins.

Giulia Anderluzzi, Michela Ghitti, Anna Maria Gasparri

|Aug 27, 2023
A simple and robust nanosystem for photoacoustic imaging of bladder cancer based on α5β1-targeted gold nanorods.

Massimo Alfano, Elisa Alchera, Angelina Sacchi

|Dec 23, 2022
Neuropilin-1 and Integrins as Receptors for Chromogranin A-Derived Peptides.

Angelo Corti, Giulia Anderluzzi, Flavio Curnis

|Jul 27, 2022
Targeting the Blood-Brain Tumor Barrier with Tumor Necrosis Factor-α.

Angelo Corti, Teresa Calimeri, Flavio Curnis

Pageof 2